Paragon Bioteck Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Paragon Bioteck

Access the complete profile.

Paragon Bioteck Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	4640 Sw Macadam Ave., Suite 80 Portland, OR 97239

Note: Revenues for privately held companies are statistical evaluations.


Paragon Bioteck's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Paragon Bioteck's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Paragon Bioteck is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Paragon Bioteck Annual Revenue and Growth Rate

Paragon Bioteck	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Paragon Bioteck's revenues are gauged from an analysis of company filings.

Paragon Bioteck's Income Statement (based on Industry Averages)

Paragon Bioteck P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Paragon Bioteck is developing and marketing. Paragon Bioteck doesn't have any recent trademark applications, indicating Paragon Bioteck is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GONIOVIZ Pharmaceutical preparations for the treatment and prevention of ocular diseases and disorders	04/08/2021
GONIOSOL Pharmaceutical preparations for the treatment and prevention of ocular diseases and disorders	04/08/2021
CLIREON Animal healthcare products, namely, veterinary preparations for treatment of animals' wounds and skin irritations	11/12/2020

See all trademarks and details in the Full Report.

Market Share of Paragon Bioteck's Largest Competitors

A competitive analysis shows these companies are in the same general field as Paragon Bioteck, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Paragon Bioteck. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RODDA PAINT	Portland, OR	100
KANTO	Portland, OR	34
FIORAVANTI CUSTOM PRODUCTS	Portland, OR	14
LACAMAS LABORATORIES	Portland, OR	10
OMIC USA	Portland, OR	8
WALKER EMULSIONS	Portland, OR	6
PARAGON BIOTECK	Portland, OR	3
PREMIER FINISHES	Portland, OR	2
BIRD CONTROL SYSTEMS	Portland, OR	2
OLIO E OSSO	Portland, OR	1

Future Competition: Paragon Bioteck's Fastest Growing Competitors

These companies are in the same general field as Paragon Bioteck and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)